Stephen Kanes, Chief Medical Officer at Sage Therapeutics, Inc. (SAGE), sold 22,948 shares at $150.00 ($3.4M) on 2019-02-08, disclosed to the SEC on 2019-02-08.
Open-market sale of $3.4M SAGE by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| SAGE | SELL | 2015-09-29 | $279K | — | Filing → |
| SAGE | SELL | 2015-09-01 | $637K | — | Filing → |
| SAGE | SELL | 2015-07-29 | $347K | — | Filing → |